Cardiovascular Drugs Market is Expected to Grow Drastically, Assured By Experts

Some of the common cardiovascular diseases include hypertensive heart disease, rheumatic heart disease, ischemic heart disease, inflammatory heart disease, and cerebrovascular heart disease. Major problems associated with hypertensive heart disease include angina, hypertrophy, and heart failure. These problems are caused due to high blood pressure in the heart’s arteries and muscles, which causes narrowing of arteries and thickening and enlargement of heart. The global cardiovascular drug market is primarily driven by increase in prevalence of heart diseases coupled with rising geriatric population and lifestyle related diseases. In order to cater to this increasing population suffering from cardiovascular diseases, drugs for treatment and prevention for these diseases is required. Rising number of diabetic patients is also expected to be another factor for growth of the global cardiovascular drugs market. According American Diabetes Association, in 2015, 30.3 Americans had diabetes, which is 9.4% of the total U.S population.

Download PDF Brochure of This Business Report @ https://www.coherentmarketinsights.com/insight/request-pdf/1167

Manufacturers in the market are focusing on mergers and acquisition and new product launches, which is positively affecting the market growth. However, stringent drug approval process and side effects of some cardiovascular drugs hamper growth of the global cardiovascular drugs market. Moreover, the patent expiry of various blockbuster drugs is also expected to adversely affect revenue growth of the global cardiovascular drugs market.

According to American Heart Association (AHA), in 2013, cardiovascular diseases accounted for over 17.3 million deaths globally, representing 31% of all global deaths. The global number is expected to rise to 23.6 million by 2030. In 2010, the global burden of cardiovascular diseases was US$ 863 billion, and it is expected to rise to US$1044 billion by 2030. Around 2,200 U.S. citizens die due to cardiovascular diseases, everyday, which is one death in every 40 seconds. Moreover, coronary heart disease accounts for (45.1%) of the total cardiovascular disease, followed by stroke (16.5%), high blood pressure (9.1%), heart failure (8.5%), diseases related to arteries (3.2%), and other cardiovascular diseases in the U.S.

Cardiovascular Drugs Market - Competitor Analysis

Some of the major players operating in the global cardiovascular drugs market are Pfizer Inc., Bayer AG., Novartis AG., Merck and Co. Inc., AstraZeneca Plc, Bristol Myers Squibb Company, Abbott Laboratories, Sun Pharma Industries, Gilead Sciences Inc., Otsuka Holdings Co., Ltd. Takeda Pharmaceutical Company Ltd, Eli Lilly and Company, and Johnson & Johnson.

Global Cardiovascular Drugs Market Taxonomy

On the basis of drug class, the global cardiovascular drugs market is segmented into:

• Anti-Hypertensive
• Anti-Hyperlipidemics
• Anti-Coagulants
• Anti-Arrhythmic
• Anti-Fibrinolytic
• Others (antianginal drugs, cardiac glycosides, and anti-ischemic drugs)

On the basis of distribution channels, the global cardiovascular drugs market is segmented into:

• Retail Pharmacies
• Hospital Pharmacies
• Online Pharmacies

To know the latest trends and insights prevalent in the cardiovascular drugs market, click the link below: https://www.coherentmarketinsights.com/ongoing-insight/cardiovascular-drugs-market-1167

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah

Coherent Market Insights

1001 4th Ave,

#3200

Seattle, WA 98154

Tel: +1-206-701-6702

Email: sales@coherentmarketinsights.com

Blood Collection Devices Market Developments and Forecast 2018-2026

Blood collection devices plays a crucial role in the patient treatment. For the treatment, blood samples are collected to measure the basic metabolism components such as blood urea nitrogen, sodium, potassium, creatinine, magnesium, chloride, and also used to measure blood glucose and lipid levels. In the recent years, as technology has increased in availability and complexity, the experts in the laboratories are receiving wide range of opportunities and challenges. In case of opportunity, automated method of collection enables technologists to perform a greater variety of tests on smaller sample quantities with greater accuracy of outcomes than the manual blood collection process. Therefore, there is an increasing number of laboratories taking their pace in the market from their hematology and chemistry analyzers to automated platforms.

Request a Sample Copy of Blood Collection Devices Research Report @ https://www.coherentmarketinsights.com/insight/request-sample/1160

Increasing prevalence of certain disease conditions such as cancer, HIV/AIDS, diabetes, coronary heart disease, and anemia are the driving factor for the growth of the blood collection devices market. In addition, increasing numbers of surgeries and high demand for blood transfusion and casualty cases are further driving the growth of blood collection devices market. According to the Centers for Disease Control and Prevention (CDC), the U.S. reported 26,203 cases of Lyme disease for the period between 2006 and 2016. According to the same source, around 10,265 deaths were reported due to alcohol-impaired crashes in 2015 which accounted for around 29% of all traffic-related deaths in the U.S.

Continuous product advancement in blood collection devices fuel the growth of the market

Tasso, Inc., a company engaged in the manufacture of HemoLink, a simplified blood collection device used in the various diagnostic application received the US$ 3 million funding from Defenses Advanced Research Projects Agency (DARPA) to advances their HemoLink technology by collaborating with GenTegra LLC, a company engaged in the manufacture of product used in the biopreservation, biobanking and in vitro diagnostics. Moreover the continuous product development and future advances in the blood collection techniques are expected to propel the growth of blood collection devices market.

Key players in the blood collection devices market:

Some of the key players in the blood collection devices market includes Becton, Dickinson and Company, NIPRO Medical Corporation, Terumo Medical Corporation, Medtronic plc, Qiagen, Bio-Rad Laboratories, Inc., Haemonetics Corporation, and Fresenius SE & Co. KGaA.

Blood Collection Devices Market Taxonomy:

On the basis of type, blood collection devices market segmented into:

• Blood collection tubes

- Serum collection tubes

- Plasma collection tubes

- Heparin tubes

- Other tubes (EDTA, ESR and Microcapillary tubes

• Needles & syringes
• Lancets
• Vacuum blood collection system
• Microfluidic system
• Blood bags
• Accessories

Browse In-Depth Analysis Research Report @ https://www.coherentmarketinsights.com/ongoing-insight/blood-collection-devices-market-1160

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah

Coherent Market Insights

1001 4th Ave,

#3200

Seattle, WA 98154

Tel: +1-206-701-6702

Email: sales@coherentmarketinsights.com

Orthopedic Prosthetic Devices Market to See Modest Growth Through 2026

Orthopedic prosthetic devices are defined as external medical devices that substitute a missing skeletal part. Orthopedic prosthetics are a vital components for rehabilitation of injured or harmed skeletal system, associated musculature and joints. These devices are mainly used after trauma or surgical removal of body appendage, disability arising from congenital condition, or disabling illnesses.

Rising prevalence of lower limb amputation among diabetic patients is expected to boost growth of the orthopedic prosthetic devices market

A major driver for market growth is the rising prevalence of lower limb amputations among diabetic patients such as diabetic foot problems, which is caused by changes in the blood vessels and nerves that leads to ulceration and subsequently leads to limb amputation. According to World Health Organization (WHO), as of 2017, 170 million people are estimated to be suffering from diabetes globally. Additionally, increasing number of trauma cases across the globe, is in turn, increasing the demand for orthopedic prosthetic devices and products. According to World Health Organization (WHO), 2017, around 50 million people are severely injured in road accidents every year across the globe. However, high costs of orthopedic products are expected to hinder the market growth.

For Better Understanding – You Can Request Sample Copy of Report Before Buying Here: https://www.coherentmarketinsights.com/insight/request-sample/1150

North America is expected to be the growth engine of the market

The global orthopedic prosthetic devices market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America is expected to hold a dominant position in the global orthopedic prosthetic devices market, owing to rising number of lower limb amputations among diabetic patients as well as affordability of these devices provided with customization and innovation. For instance, in September 2017, Zimmer, introduced an innovative persona partial knee system that is known to alleviate pain, restore mobility, and improve the quality of life of the patients. Asia Pacific is expected to witness significant traction in the global orthopedic prosthetics devices market, owing to the changing healthcare scenario and development of new policies and regulatory fronts in countries in the region. For instance, the formulation of Indian Certification of Medical Devices (ICMD) by the Indian Healthcare regulatory body is expected to bring credibility to the devices manufactured by regional companies, in turn driving growth of the orthopedic prosthetic devices market.

Novel innovations in prosthetic devices adopted by key players to establish significant position in the global orthopedic prosthetic devices market

Key players operating in the global orthopedic prosthetic devices market include Smith & Nephew, Stryker Corp., DePuy Synthes, Zimmer Biomet, Medtronic Spinal, DJO Global, Integra Lifesciences, NuVasive Inc., Globus Medical, and Wright Medical. The key players are focusing on strategic mergers and acquisitions and development of innovative systems. For instance, in October, 2017, Zimmer Biomet Holdings Inc., introduced Avenue T TLIF Cage (Avenue T) in the U.S. Avenue T manufactures advancements in the posterior lumbar cage technology, through incorporation of VerteBRIDGE plating. The plating facilitates intra-discal fixation and cage insertion through minimally invasive procedure. Avenue T joins the previously introduced family of its product line of cages, including Avenue L Lateral Lumbar Cage, ROI-C Cervical Cage, and ROI-A ALIF Cage with VerteBRIDGE plating. Avenue T is the first product with posteriorly implanted cage, integrated with anti-migration fixation.

Market Taxonomy

On the basis of device type, the global orthopedic prosthetic devices market is segmented into

• Upper Extremity Prosthetics
• Lower Extremity Prosthetics
• Sockets
• Modular Components
• Liners

On the basis of technology, the global orthopedic prosthetic devices market is segmented into

• Electric Powered
• Conventional
• Hybrid Orthopedic Prosthetics

To know the latest trends and insights prevalent in the orthopedic prosthetic devices market, click the link below: https://www.coherentmarketinsights.com/ongoing-insight/orthopedic-prosthetic-devices-market-1150

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah

Coherent Market Insights

1001 4th Ave,

#3200

Seattle, WA 98154

Tel: +1-206-701-6702

Email: sales@coherentmarketinsights.com

Hot and Cold Therapy Packs Market to Experience Significant Growth By 2026

Heat and cold therapy is a non-invasive and non-addictive pain relief therapy used for muscle relaxation, improving blood circulation, and reducing swelling. Heat and cold therapy is the most effective, inexpensive, and rapid relief treatment therapy. Different types of injuries cause swelling and inflammation, for which application of ice decreases the blood flow towards injury thereby, reducing the swelling and inflammation. However, heat therapy aids in increasing blood flow in turn supplying nutrients and oxygen in order to relax the ligaments and muscle. Heat is applied by electric or microwave heating pads, hot water bath or gel packs. Whereas, cold therapy is consists of ice or cold gel packs. Heat and cold therapy are good for strains, sprains, and bruises that occur during heavy physical or sports training sessions.

Request a Sample Copy: https://www.coherentmarketinsights.com/insight/request-sample/1133

Increasing adoption of non-surgical and non-pharmaceutical pain relive management therapies is expected to boost growth of the hot and cold therapy packs market

According to World Health Organization (WHO) 2015, approximately 8 million individuals face minor accidents, every day. Thus, minimal injuries due to accidents and its treatments to relieve the pain are factors expected to fuel the hot and cold therapy packs market growth. Moreover, according to the Arthritis Foundation, cold packs are best for severe pain in body parts whereas, heat treatment such as warm baths and heating pads are likely to aid in relaxing stiff joints and muscles.

Enhanced access to healthcare services such as easy availability of pain and injury relief therapies and increased personal health care spending are factors anticipated to boost the hot and cold therapy packs market growth. Moreover, market is witnessing growth due to increasing inclination of the populace towards non-surgical pain solutions and wound management for pain relief. For instance, according to a study conducted by University of Leiden in 2015, majority of surgeons recommended non-surgical treatments such as physical therapy or acetaminophen therapy for the treatment of osteoarthritis. Moreover, geriatric population suffering from chronic illness such as osteoporosis and arthritis prefer home care such as hot and cold therapy packs instead of frequently visiting hospitals or consuming drugs. The use of hot and cold therapy packs is safer and easy as compared to drugs and physiotherapy treatment. Thus, increasing non-pharmacological cure treatment for pain relive especially in geriatric population is a driving factor for growth of the market. However, increasing adoption of herbal and reusable packs for pain relief are factors expected to hinder the market growth.

Top Key Players

Major key players in the global hot and cold therapy packs markets include 3M, Caldera International Inc., Cardinal Health, Chattanooga Group Inc., Halyard Health, Inc., Beiersdorf Australia Ltd., Breg, Inc., Corso Enterprises, Inc., Covidien plc., Core Products International, Inc., DJO Global, Inc., Kobayashi Pharmaceutical Co., Ltd., Medline Industries, Inc., Bruder Healthcare Company, Inc., Thermionics Corp., and Carex Health Brands.

Market Taxonomy

The global hot and cold therapy packs market is segmented on the basis of product type, application type, distribution channel, and geography.

On the basis of application type, the global hot and cold therapy packs market is segmented into:

• Accident
• Injury
• Mastitis
• Pain management
• Others

On the basis of product type, the global hot and cold therapy packs market is segmented into:

• Therapy pads
• Gel Packs
• Instant Packs
• Bottle System
• Patch
• Wraps
• Others

For More Information, Browse Full Report Here: https://www.coherentmarketinsights.com/ongoing-insight/hot-and-cold-therapy-packs-market-1133

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah

Coherent Market Insights

1001 4th Ave,

#3200

Seattle, WA 98154

Tel: +1-206-701-6702

Email: sales@coherentmarketinsights.com

Tissue Diagnostic Market Forecast To 2026 Insights Shared In Detailed

Tissue diagnosis is important tool in diagnosis, monitoring, and management of different types of cancer conditions. Recognition of sign and symptoms of disease are done through biopsy, a process of taking sample from region of interest such as skin, tissue or tumor for further diagnosis. Biopsy are primarily done to look for cancer detection or to detect rejection of transplanted organ draft.

Biopsy is done to identify likely cause of cancerous and non-cancerous tissue, which are unable to detect through CT-scan or X-rays. Depending on area of sample collection various biopsy procedures are done such as endoscopic biopsy, bone marrow biopsy, skin biopsy, kidney biopsy, liver biopsy, and prostate biopsy. Furthermore biopsy can be done using needle biopsy, CT guided biopsy, Ultrasound biopsy, and surgical biopsy for the tissue diagnostic. According to the American journal of Nephrology, 2015, Australia has the highest numbers of annual renal biopsy rates (215 persons/million person/year) followed by the Finland (176 persons/million person/year) and U.S. (175 persons/million person/year). The increased numbers of biopsy procedure likely to fuel the growth of tissue diagnostic market, in near future.

Get Exclusive Sample Copy of Tissue Diagnostic Research @ https://www.coherentmarketinsights.com/insight/request-sample/1112

Rising prevalence of different cancer incidences is major driving factor boosting the tissue diagnostic market. According to American cancer Society (ACS), 1.6 million new cases of cancer diagnosed in the U.S., in 2016. In addition, increase research funding in cancer treatment and growing healthcare expenditure likely to show gradual rise in tissue diagnostic market. National Cancer Institute, in 2015, spends US$ 4,480 million on various types of cancer research which includes breast cancer, colorectal cancer, cervical cancer, liver cancer, lung cancer, leukemia, ovarian cancer and uterine cancer.

Rise in the prevalence of cancer incidences to boost the tissue diagnostic market

According to the United States Cancer statistics report published in 2014 by Centers of Disease Control and Prevention (CDC), between 1999 and 2014, more than 1600 people a day, died due to the cause of cancer. Although screening tests helps to detect cancer condition at early stage, data from Healthy People 2020, an initiative form Department of Health and Human Services, reveals that screening rate is still below the national targets set. Combined data collected from CDC and National cancer institute (NCI) focus on the top 3 cancer incidences in male and female. In male prostate cancer incidence are higher, while in females breast cancer are most dominated, followed by lung and colon cancer respectively in both male and female.

New and advanced methods of tissue diagnosis favors the market growth

Innovation in tissue diagnostic process for the efficient diagnostic testing such as Fluorescence in situ hybridization (FISH), Immunohistochemistry (IHC) and In situ hybridization (ISH) raises the opportunity to grow tissue diagnostic market in future. In September 2017, researchers at the University of Texas, developed a new way of diagnosis by creating pen named as “MasSpec Pen”, which is handheld devices able to distinguish healthy tissue and tumor tissue in just 10 seconds, more than 150 times quicker than existing technology. These new tool provides improvement in cancer treatment and minimizes the chances of recurrence by offering precise diagnostic information, which eventually favors the growth in tissue diagnostic market.

Global Eminent Players

Key players operated in the tissue diagnostic market are Biocare Medical, Agilent technologies, Thermo Fisher Scientific, Sigma-Aldrich, Roche Diagnostics, Danaher corp., Biogenex Laboratories, Life Technologies and Abbott laboratories.

Tissue diagnostic market taxonomy:

By Technology:

• In situ hybridization
• Digital pathology
• Immunohistochemistry
• Tissue microarray
• Special staining

By Disease:

• Breast cancer
• Lymphoma cancer
• Gastric cancer
• Prostate cancer

Browse In-Depth Analysis Research Report @ https://www.coherentmarketinsights.com/ongoing-insight/tissue-diagnostic-market-1112

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah

Coherent Market Insights

1001 4th Ave,

#3200

Seattle, WA 98154

Tel: +1-206-701-6702

Email: sales@coherentmarketinsights.com

Hypodermic Needles Market - Application Recommendations By Global Experts 2026

Hypodermic needles are hollow needles that are attached with hypodermic syringes for injecting saline solution or solution containing liquid medicines and drugs. These needles are also useful in extraction of fluids such as blood from the body. Hypodermic needles can be used as disposable as well as reusable needles. The reusable needles must be sterilized before use due to their ability to cause various diseases or infections that might transmit if they are not sterile. Disposable hypodermic needles aids an important role in research environments where sterile conditions are required and it also reduces contamination significantly during inoculation of a sterile substrate. Thus, preventing colonization of airborne pathogens on the needles surface. Hypodermic needles are primarily of two types, which include safety and non-safety hypodermic needles. Safety hypodermic needles are the needles on the safety syringe that can be permanently attached or detachable thus preventing healthcare professional from needle stick injuries. Whereas, non-safety hypodermic needles are the conventional syringe needles, which lack safety mechanisms thereby possessing higher chances of needle stick injuries.

Get In-Depth Sample Copy of Hypodermic Needles Market Research Report @ https://www.coherentmarketinsights.com/insight/request-sample/1102

Rising demand for vaccines is expected to boost the hypodermic needles market

The factors that are contributing to the growth of hypodermic needles market are rising demand for intravenous vaccines delivery mode. There are numerous vaccines that are recommended for injection into muscle (intramuscularly) although some are delivered through subcutaneously and intradermally. Furthermore, increasing prevalence of chronic diseases and rising compliance for safety needles so as to curtail the incidences of needle stick injuries are the other factors that are contributing to the growth of hypodermic needles. However, rising incidence of needle stick injuries and risk of infections associated with administering drugs using hypodermic needles are hindering the growth of hypodermic needles market.

The innovative K pack Surshield launched by Terumo Medical Corporation is expected to propel the market growth

The key players in the hypodermic needles market include Albert David, Becton, Connecticut Hypodermics, Retractable Technologies, Novo Nordisk, BD, Covidien, Terumo Medical Corporation, Dickinson, Vygon, Vita Needle Company, Unilife Corporation, Hindustan Syringes & Medical Devices Limited, and Nipro Medical Corporation. The key players are focusing on strategic mergers and acquisition and development of innovative systems. For instance, Terumo Medical Corporation has launched an innovative hypodermic needle known as K-Pack Surshield in 2012, which has an integrated passive sharps protection feature with pre filled syringes. The device is used to allow automated manipulations during the packaging process, which makes it ideal for inclusion and bundling into the secondary packaging of parenteral medication.

Hypodermic Needles Market Taxonomy:

Hypodermic Needles Market is segmented on the basis of Product type, end user, and geography

On the basis of product type, hypodermic needles market is segmented into:

• Safety hypodermic needle
  
  • Passive hypodermic needle
    
    • Retractable hypodermic needle
      
    • Non- retractable hypodermic needle
      
  • Active hypodermic needle
    
    • Retractable hypodermic needle
      
    • Non – retractable hypodermic needle
      
• Non safety hypodermic needle
  

Browse In-Depth Analysis Research Report @ https://www.coherentmarketinsights.com/ongoing-insight/hypodermic-needles-market-1102

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah

Coherent Market Insights

1001 4th Ave,

#3200

Seattle, WA 98154

Tel: +1-206-701-6702

Email: sales@coherentmarketinsights.com

Gas Chromatography Market Demands and Gross Margin Analysis 2026

Gas chromatography is a technique used for analyzing and separating compounds that can vaporize without decomposing. It is used to test purity and quality of substances, analyze biological specimen, and forensics. Moreover, gas chromatography and mass spectrometry (GC-MC) is also used to detect drugs, identify and investigate unknown and explosive samples. Gas chromatography a wide range of application in various field such as chemicals, healthcare, oil and gas, agriculture, academics and research institutes, forensic, environmental, and clinical toxicology. In biotechnology and pharmaceutical domain, gas chromatography is used for analytical research and development, drug formulations and production, quality control, and quality assurance. Furthermore, it is used in detection of nucleic acid, proteins, fats, carbohydrates, vitamins and metabolic profiling. Advancements in technology in gas chromatography products such as GC-2010 plus and GC-2014, which are temperature-programmed chip-based GC helps to decrease analysis time, enhance performance, and provide accuracy.

Request a Sample Copy: https://www.coherentmarketinsights.com/insight/request-sample/1092

Global Gas chromatography Market – Trends and Opportunity

Researchers are more focused on innovation in gas chromatography, in order to improve robustness, selectivity, and sensitivity. For instance, in May 2017, Electronic Sensor Technology Inc., developed and received patent for its breakthrough chemical vapor analysis process. This process is applied on gas chromatography calculations. This technology several advantages in life science, chemical and petrochemical, environmental, and food and beverages sectors. This is owing to the accuracy and real-time analysis of chemical odors and vapors, which helps in investigation of bacteria. Moreover, in February 2017, Ellutia Chromatography Solutions Co. launched 500 series of Ultra-Fast Gas Chromatography (UFGC) with features such as air blown oven and directly heated columns. These help in increasing ramp rates, upper temperatures limits and decreases cool down times reducing energy consumption. Such features help in reducing cycle time by up to 10 times. Therefore, it is a less time consuming process, which is favorable for growth of the gas chromatography market.

In September 2017, PerkinElmer, Inc. launched Clarus 590 and 690 gas chromatography instruments. It has features such as comprehensive portfolio of sampling accessories, TurboMatrix headspace and thermal desorption options, along with the new TurboMatrix MultipPrep technology. It offers more flexibility and higher throughput and optimized injection, which helps to detect harmful contaminants in food, environment, petrochemical, and pharmaceutical samples. Thus, advancement in technology and beneficial features of these instruments caters to various industry demands, which directly favors growth of the gas chromatography.

Increasing GC adoption by various industries is expected to favor growth of the gas chromatography market

Increasing adoption of gas chromatography by various industries is major factor fueling growth of gas chromatography market. Moreover, increasing private and government investments in research and development for drug formulation and development is another key factor that will support the growth of gas chromatography market.

Rising awareness about therapeutic-based application will boost growth of the gas chromatography market in the near future.

Key Players

Major players in the gas chromatography market are Thermo Fisher Scientific, Inc., CMC Instruments, Agilent Technologies, LECO Corporation, GmbH Rudolf Dieselstrasse and Shimadzu Corporation.

Global Gas chromatography Market taxonomy –

By Instrument –

• Systems
• Auto-Samplers
• Faction Collectors
• Detectors

By Accessories and Consumables –

• Column
• Fittings And Tubing
• Auto-Samplers Accessories
• Pressure Regulator
• Gas Generator

Browse In-Depth Analysis Research Report @ https://www.coherentmarketinsights.com/ongoing-insight/gas-chromatography-market-1092

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah

Coherent Market Insights

1001 4th Ave,

#3200

Seattle, WA 98154

Tel: +1-206-701-6702

Email: sales@coherentmarketinsights.com

Cell Free Protein Expression Market Value Projected to Expand by 2017 to 2025

Cell free protein expression is also called as cell-free protein synthesis, in vitro translation, cell-free translation or in vitro protein expression. It is a well-developed, rapid, and efficient technique for synthesizing proteins in cell lysates rather than cultured cells. Cell free protein expression uses translation machineries to extract the desired cells. It can be done by using various types of mammalian cells, bacteria, plants, and insect cells over conventional in vivo method. For instance, cell free protein expression system works independently and is free of any cellular context, owing to these benefits it is ideal for high-throughput screening of mutagenesis. Moreover, the whole machinery of cell free expression system sets better environment to manufacture membrane proteins, toxic proteins, and proteins that can undergo degradation. Pharmaceutical and biotechnological industries actively utilize these tools for research and developmental activities as well as for genomics and proteomics. Thus, it is a key factor propelling the cell free protein expression market growth over the forecast period.

The global cell free protein expression market sizewas valued at US$ 177.1 million in 2017, and is expected to witness a CAGR of 6.2% over the forecast period (2018 – 2026).

Get the inside scoop of the Sample report @ https://www.coherentmarketinsights.com/insight/request-sample/1082

Robust research and development is expected to drive growth of the cell free protein expression market

Increasing research and development in the field of proteomics and genomics and high prevalence of infectious disease and cancer are the major factors driving growth of the cell free protein expression market. For instance, According to 2012, EU Industrial R&D Investment Scoreboard, the pharmaceutical and biotechnology sectors represented 17.7% of business R&D expenditure in the world. Moreover, high prevalence of infectious disease and cancer cases across the world are resulting into high adoption of cell samples for research and development of drugs thus, expected to have a meteoric growth for the cell free protein expression market. For instance, According to the estimates by GLOBOCAN 2012, an estimated 850,000 new cancer cases were diagnosed in Africa, while almost 600,000 deaths were attributed to malignant disease. The number of cancer cases is expected to rise to 1,056,000 by 2020.

Cell Free Protein Expression Market- Regional Analysis

Cell free protein expression market is segmented into six major regions- North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. Increasing cell-based research in North America due to high demand for precision medicine is a major factor driving growth of the cell free protein expression market in this region. In 2015, the Precision Medicine Initiative was launched in the U.S. to revolutionize the treatment of diseases, which include cancer and other chronic diseases, as precision medicine offers tailored treatment for an individual according to genetic makeup of the person. Furthermore, increasing emphasis on proteomics and genomics research activities in UK, Germany, France, and Switzerland are fueling growth of the European cell free protein expression market.

Cell Free Protein Expression Market- Competitive Landscape

Key players operating in cell free protein expression market include iBio CDMO LLC, Thermo Fisher Scientific Inc., Takara Bio, Inc., New England Biolabs, Promega Corporation, CellFree Sciences Co., Ltd., Biotechrabbit GmbH, Bioneer Corporation, Cube Biotech GmbH, Jena Bioscience GmbH, and GeneCopoeia, Inc.

Detailed Segmentation:

Global Cell Free Protein Expression Market, By Application:

• Therapeutic Application
• Research Application

Global Cell Free Protein Expression Market, By Product Type:

• Expression Systems
• Prokaryotic Expression Systems
• Mammalian Cell Expression Systems
• Insect Cell Expression Systems
• Yeast Cell Expression Systems
• Other Systems
• Consumables and Other Products

To know the latest trends and insights prevalent in the keyword market, click the link below: https://www.coherentmarketinsights.com/market-insight/cell-free-protein-expression-market-1082

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah

Coherent Market Insights

1001 4th Ave,

#3200

Seattle, WA 98154

Tel: +1-206-701-6702

Email: sales@coherentmarketinsights.com

Patient Warming Devices Market Analysis and Development Trends 2018-2026

Patient warming devices are used by healthcare professionals during surgeries and for intra-hospital patient transfer. Severely wounded patients may suffer or die from hypothermia and these patient warming devices have proven to be very effective in such cases. Physiological temperature often drops down during major operations such as cardiovascular and others, where rewarming becomes important so as to avoid any complications during the procedure. Patient warming devices can help to achieve normothermia by preventing any sudden body heat loss, leading to faster recovery.

Request Sample Copy: https://www.coherentmarketinsights.com/insight/request-sample/1073

Patient warming devices include catheters, temperature monitors, and cooling jackets. Hot intravenous fluid is introduced via catheter in the patient’s system, while monitoring the temperature between 50o C and 100o C, avoiding any tissue damage. To avoid any significant entry site and endothelial damage due to hot fluid, the catheter is surrounded by a cooling jacket, which carries unheated fluid between the gaps. Patient warming devices can substantially decrease chances of postoperative wound infection and myocardial infarctions, mortality rates, and ICU time, along with hospital stay. These factors are accelerating growth of the patient warming devices market.

Rising number of surgical procedures is expected to boost the market growth

Anesthesia in surgery procedures causes a perioperative temperature drop in patients and is the main cause of inadvertent perioperative hypothermia (IPH), which requires instant management. According to American Society of Anesthesiologists (ASA), successful surgery outcomes can be assured with the help of extensive perioperative temperature management within the normothermic range. Furthermore, ASA states that around 50% of the U.S. surgical patients suffer from IPH, which can be reduced by using patient warming devices, in turn, fueling growth of the patient warming devices market.

Increasing prevalence of chronic diseases, primarily cardiovascular and cancer conditions, require patients to undergo surgeries in critical cases. According to World Health organization (WHO), around 300 million surgeries were performed in 2012, the number for which has exponentially increased over the recent past, in turn, boosting growth of the patient warming devices market.

North America is expected to hold a dominant position in the market over the forecast period due to increasing prevalence of chronic diseases, robust healthcare infrastructure, and growing geriatric population, which is highly susceptible to cardiovascular diseases. According to Agency for Healthcare Research and Quality (AHRQ), 22 million surgeries were performed in 2014, which in turn, has driven growth of the patient warming devices market. Asia Pacific is expected to witness highest growth rate over the forecast period due to factors such as improving healthcare infrastructure, government efforts towards improving healthcare facilities, and increasing medical tourism. For instance, in 2014, Indonesia’s government launched Jaminan Kesehatan Nasional, a programme, which aims to provide basic care to the entire country by 2019.

Key Players

Key players operating in the patient warming devices market include 3M Health Care, Smiths Medical, Medtronic plc, ZOLL Medical Corporation, Stryker Corporation, GE Healthcare, Philips Healthcare, C. R. Bard, Inc., and Inspiration Healthcare.

Patient Warming Devices Market Taxonomy

The global patient warming devices market is segmented on the basis of product type, application, end user, and geography

On the basis of product type, the global patient warming devices market is segmented into:

• Surface Warming System
• Intravascular Warming System
• Patient Warming Accessories

On the basis of application, the global patient warming devices market is segmented into:

• Acute Care
• Perioperative Care
• New Born Care
• Others

Browse In-Depth Analysis Research Report @ https://www.coherentmarketinsights.com/ongoing-insight/patient-warming-devices-market-1073

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah

Coherent Market Insights

1001 4th Ave,

#3200

Seattle, WA 98154

Tel: +1-206-701-6702

Email: sales@coherentmarketinsights.com

Medical Devices Market Research Approach and Methodology with Forecast

Medical devices are an integral part of the healthcare industry as they play an important role right from diagnosis up to the end stage of any disease management. Medical technology is already capable of diagnosing, monitoring and treating every disease or condition that is affecting globally. Technology innovators have focused on reducing costs for patients as well as healthcare professionals. Increased life expectancy, aging population, high prevalence of chronic diseases and associated comorbidities has been a driving force behind the innovation associated with medical technology. The Global Medical Devices Nomenclature (GMDN) Agency determines the categories under which a particular medical device falls. Few of the categories includes active implantable technology, dental technology, hospital hardware, and in-vitro diagnostic technology.

Request for Sample Copy of Research @ https://www.coherentmarketinsights.com/insight/request-sample/1065

Mergers & acquisitions have been a strategic maneuver for the manufacturers to stay competitive amongst cutthroat competition. For instance, Abbott Laboratories’ acquisition of St. Jude Medical was the biggest merger of the year 2016, which was completed in 2017. This acquisition added chronic pain management business to Abbott’s portfolio and other cardiovascular offerings. This acquisition has converted Abbott into a major player in the cardiovascular business. The total revenue of top 10 global medical device manufacturers for 2016 accounted for US$ 166.4 billion.

Outlook of top 10 organizations in the medical devices industry (2016)

Top 10 medical device manufacturers in 2016, according to the rank include,

Medtronic Plc

Johnson & Johnson

General Electric Co.

Fresenius Medical Care AG & Co. KGAA

Philips Healthcare

Siemens AG

Becton, Dickinson and Co.

Cardinal Health Inc.

Stryker Corp.

Baxter International Inc.

These rankings have been given according to the sales revenues for respective organizations for 2016 in global medical devices industry.

1. Medtronic Plc is a global medical device manufacturing organization and earned US$ 29 billion revenue through medical devices sales and distribution in 2016. The company currently functions in four main operating segments namely, cardiac & vascular group, minimally invasive therapies group, restorative therapies group, and diabetes group. Cardiac & vascular group accounted for highest revenues in the year 2016, i.e., US$ 10.2 billion, The major competitors in the cardiac and vascular group include St. Jude Medical, Inc., Boston Scientific Corporation, Sorin Group, Edwards Lifesciences Corporation, and C.R. Bard, Inc.

2. Johnson & Johnson operates through three major segments which include pharmaceuticals, consumer and medical devices. The company has planned to drive the growth further in the global medical devices sector through at least 12 planned product launches in 2017 and has capitalized on various acquisitions, in 2016, in the medical device sector. For instance, acquisition of Abbott Medical Optics and Megadyne Medical Products, Inc. in 2016, by Ethicon, a part of the Johnson & Johnson medical devices companies.

3. Fresenius Medical Care is global leader in providing products and services for chronic kidney failure management. Almost 70% of the company’s revenue comes from dialysis services which include dialysis machines, dialyzers, and bloodline systems. The dialysis products accounted for around 34% of the global market in 2016. The company’s strategy revolves around dominating select global medical device sectors through product innovation and internal market analysis. Fresenius Medical Care has developed its own tool, the Market and Competitor Survey (MCS) which is used to collect and analyze relevant dialysis market and competitor data once a year.

4. Becton, Dickinson, and Company earned US$ 12.5 billion sales revenues in 2016 through medical devices sales and distribution. The company operates through two segments, medical and life sciences segment, out of which, medical segment is the major revenue generator for the organization. The organization invests in acquisitions to compete in the market as well, as the company acquired CareFusion Corporation in 2015.

5. Baxter International, Inc. operates through two business segments, namely hospital products and renal products. These segments consist of medical devices as well as IV drug solutions and IV administration associated products and accessories. The company’s product portfolio has substantial breadth and depth in terms of product lines and penetration. The company’s strong marketing strategies associated with its customers, group purchasing organizations, and end users have helped them to create a diverse and strong customer base, which is how the company has retained its position in the global medical devices market.

Global medical devices market is impacted by various factors from macro to microeconomic with respect to individual organizations. However, competition, and price pressure has led to integration of information technology in healthcare, continuous innovation, customer centricity, and change in distribution channel. Top technological trends such as revolution in diabetes care, 3D printing, medical robots, and engineered blood vessels, are among other notable trends are expected to affect the global medical devices market over the foreseeable future.

To know the latest trends and insights prevalent in the medical devices market, click the link below: https://www.coherentmarketinsights.com/ongoing-insight/medical-devices-market-global-competitive-analysis-1065

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah

Coherent Market Insights

1001 4th Ave,

#3200

Seattle, WA 98154

Tel: +1-206-701-6702

Email: sales@coherentmarketinsights.com

Laboratory Filtration in Health Care Market Trends and Opportunities to 2026

Filtration has a wide laboratory-scale applications as it is used in various fields, such as research laboratories, microbial analysis, discovery and development of drugs and vaccines, and virus removal. Laboratory filtration is used in sample preparation prior to the analysis by using an instrumental analytical method such HPLC/UHPLC. Laboratory filtration is also used in instrument protection. For instance, hydrophobic filter in the pipette. Furthermore, analytical filtration are used in water quality testing to determine the microbial content of samples. Considering the wide application for laboratory filtration products, increase in the usage of analytical instruments, and introduction of advance filters is expected to drive the growth of laboratory filtration in healthcare market during the forecast period.

Download PDF Brochure: https://www.coherentmarketinsights.com/insight/request-pdf/1015

Technological advancement is expected to boost the growth of the laboratory filtration in healthcare market

The laboratory filtration market has witnessed new product launches and innovative technologies. The technological advanced product provides high reliability and throughput as compared to conventional methods. For instance, Merck KGaA Durapore 0.22 µm hydrophilic Polyvinylidene fluoride (PVDF) membranes is used in endotoxins removal and is designed for sterile filtration. Durapore also provides high protein recovery with minimal loss of valuable product. Durapore is also used for filtration of lipids in small and large volume system. Reverse Osmosis systems is an another technique that provides various benefits and widely used in laboratories as it is a physical process, which does not uses regenerating chemicals and hence, provides excellent defense against viruses, pyrogens, and bacteria making reverse osmosis systems cost-effective technique. Technological advancements in filtration products have resulted in an increase in the adoption rate, which in turn is expected to result in growth of the laboratory filtration in healthcare market.

Increasing focus towards the development of biopharmaceutical molecules and the rising application of filtration techniques are expected to contribute for the growth of the laboratory filtration in healthcare market

Companies are developing advance products for the treatment of various diseases and to develop this molecules wide range of laboratory filters are used in clinical and research institutes, which are expected to increase the demand for laboratory filtration. For instance, Ultrafiltration (UF) are widely used for the removal of suspended solids like bacteria, high-molecular-weight molecules, and endotoxin. The robust ultrafiltration processes plays crucial role in the development of bio-pharmaceutical products. Cellulose nitrate membrane filters are prepared by the reaction of nitric acid and cellulose. This filters are widely used for the filtration of peptides and proteins in molecular biology. Thus, increasing use of filtration technique in research and development of molecules is expected to support the growth of the ­­­­laboratory filtration in healthcare market.

Key Players

The key players operating in the global laboratory filtration in healthcare market include Merck Millipore, 3M Purification, Inc., Thermo Fisher Scientific, Inc., Sigma-Aldrich, Pall Corporation, Cantel Medical Corp, Sartorius Group, Macherey-Nagel Gmbh & Co., and GE Healthcare.

Global Laboratory Filtration in Healthcare Market Taxonomy –

The global laboratory filtration in healthcare market is segmented on the basis of product, technology, and end user

By Product –

• Filtration Assemblies
• Filtration Media
• Filtration Accessories

By Technology –

• Microfiltration
• Ultrafiltration
• Reverse Osmosis
• Vacuum Filtration
• Nano filtration

Browse In-Depth Analysis Research Report @ https://www.coherentmarketinsights.com/ongoing-insight/laboratory-filtration-in-health-care-market-1015

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah

Coherent Market Insights

1001 4th Ave,

#3200

Seattle, WA 98154

Tel: +1-206-701-6702

Email: sales@coherentmarketinsights.com

Video Telemedicine Market Strategies to Increase Productivity by 2026

A joint survey conducted in 2016, by American Telemedicine Association (ATA) and WEGO Health, to understand patient’s perspective on the use of video telemedicine, revealed that consumers are more interested in using telehealth as a replacement or complement technique for in-person patient care. Video conferencing in healthcare reduces re-hospitalization by extending care at home, delivers video-audio consultation, provides easy-to-use interface and reduce travel time and associated costs. In addition, video telemedicine improves efficiency by clear content sharing and facilitating more participant to engage into discussion.

Get In-Depth Sample Copy @ https://www.coherentmarketinsights.com/insight/request-pdf/1003

Video telemedicine for treating patients is important aspects of telemedicine facility, which facilitates reliable quality and clinical efficiency to in-home care, acute care and ambulatory care. Telehealth continue to gain importance in healthcare industry. Patients are realizing the value of virtual care options and substituting it for in-patient care option. Telemedicine extends the healthcare solutions to the rural patients and to the patients living in the remote location areas, which increases accessibility to care at lower costs. Healthcare professionals and independent physicians increasingly use telemedicine application and software services to video conference with patients, when they lack infrastructure for in-house patient care.

An increasing need for delivering healthcare services to rising geriatric population, growing dearth of physicians and increasing chronic disease incidence facilitates the growth of video telemedicine market. Moreover, increasing adaptation of mobile, smartphone and tablet into healthcare IT segment facilitating technology penetration and incorporation of big data to allow more efficient, more effective and improved operational efficiency in telemedicine services, further helps to boost the video telemedicine market, in near future.

Video telemedicine to become effective tool as in-person care for Parkinson’s disease

According to the study published in Neurology Journal, in April 2017, video telemedicine is expected to become a new tool to improve care for people suffering from Parkinson’s disease and essentially for those patients who do not have easy access to a neurologist. Moreover, the study finding shows that video telemedicine for chronic disease such as Parkinson’s disease is more effective than in-patient care. In addition, the broader adaptation of technology has a potential to expand the access to patient-centered care facilities.

Major Players Operating This Market

Some of the key players operating in the video telemedicine market are Huawei technologies Co. Ltd., Polycom Inc., Vidyo Inc., Adobe Systems Incorporated, Cisco Systems, Inc., Avaya Inc., ZTE Corporation, West Corporation and Microsoft Corporation.

Video Telemedicine Market Taxonomy:

On the basis of deployment, video telemedicine market segmented into:

• On-premise video conferencing
• Cloud-based video conferencing

On the basis of application, video telemedicine market segmented into:

• Oncology
• Cardiology
• Dermatology
• Gynecology
• Dentistry
• Neurology
• Others (Orthopedics, Pathology)

Browse In-Depth Analysis Research Report @ https://www.coherentmarketinsights.com/ongoing-insight/video-telemedicine-market-1003

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah

Coherent Market Insights

1001 4th Ave,

#3200

Seattle, WA 98154

Tel: +1-206-701-6702

Email: sales@coherentmarketinsights.com